A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
"The goal of treating macular degeneration is to keep as much vision as possible," notes Sarju Patel, MD, attending physician at Retinal Consultants of America. Referring patients to low-vision ...
A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...
Age-related macular degeneration (AMD) is a leading cause of blindness in the older population. Geographic atrophy is an advanced stage of dry AMD, characterized by irreversible vision loss due to the ...
People with a leading cause of blindness were able to read again thanks to a tiny wireless chip implanted in the back of the eye and specialized augmented glasses, according to study results published ...
Participants received retinal implants that restored some of their vision. Zorica Nastasic via Getty Images Today, in the New England Journal of Medicine, researchers announced that they restored some ...
An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...
The prescription of metformin was associated neither with the development of age-related macular degeneration (AMD) in participants without the condition nor with progression to advanced forms of the ...
Scientists have developed a new eyedrop that can ferry protective compounds all the way to the retina, paving the way for a less-invasive injection-free method of managing sight-stealing diseases such ...
Wet macular degeneration is a form of age-related macular degeneration (AMD), a serious eye disease that affects the macula, the central portion of the retina that’s responsible for sharp, central ...
Advances in neovascular macular degeneration, as presented at the American Society of Retina Specialists (ASRS) 2025 annual meeting, include data on efficacy and dosing intervals for aflibercept 8 mg ...
FRESNO, Calif. (KFSN) -- As we age, our vision can start to change. The older we get, we can become more at risk for eye diseases, like macular degeneration. "Other than vitamins and antioxidants, we ...